Royalty Pharma Plc (RPRX) — Cash Flow Reinvestment Rate
Royalty Pharma Plc (RPRX) has a Cash Flow Reinvestment Rate of 0.62x as of March 2026, reinvesting $470.17 Million (capex $0.00 plus investments $-470.17 Million) from operating cash flow of $760.54 Million. Explore RPRX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Royalty Pharma Plc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Royalty Pharma Plc across 11 annual periods. Also explore Royalty Pharma Plc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Royalty Pharma Plc (2002–2025)
Year-by-year capital reinvestment analysis for Royalty Pharma Plc. For live market cap and broader valuation context, see RPRX market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | $1.36 Billion | $2.49 Billion | $0.00 | ▼ -43.3% |
| 2024 | 0.97x | $2.68 Billion | $2.77 Billion | $0.00 | ▲ +4.2% |
| 2023 | 0.93x | $2.77 Billion | $2.99 Billion | $2.12 Billion | ▼ -37.7% |
| 2022 | 1.49x | $3.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +64.0% |
| 2021 | 0.91x | $1.83 Billion | $2.02 Billion | $523.00K | ▼ -65.1% |
| 2020 | 2.60x | $5.29 Billion | $2.03 Billion | $2.20 Billion | ▲ +13.0% |
| 2019 | 2.30x | $3.84 Billion | $1.67 Billion | $1.72 Billion | ▲ +342.1% |
| 2018 | 0.52x | $842.61 Million | $1.62 Billion | $269.59 Million | ▼ -74.3% |
| 2017 | 2.03x | $2.88 Billion | $1.42 Billion | $2.29 Billion | — |
| 2003 | 0.00x | $0.00 | $11.15 Million | $0.00 | ▼ -100.0% |
| 2002 | 0.01x | $49.00K | $8.45 Million | $49.00K | — |